The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
NRG-LU002: Randomized phase II/III trial of maintenance systemic therapy versus local consolidative therapy (LCT) plus maintenance systemic therapy for limited metastatic non-small cell lung cancer (NSCLC).
 
Puneeth Iyengar
Consulting or Advisory Role - AstraZeneca; Novocure
Research Funding - Incyte (Inst)
 
Chen Hu
Consulting or Advisory Role - Johnson & Johnson Enterprise Innovation Inc.
 
Daniel Richard Gomez
Honoraria - AstraZeneca; Bristol-Myers Squibb; GRAIL; Merck; Reflexion Medical; US Oncology; Varian Medical Systems; Vindico Medical Education
Consulting or Advisory Role - GRAIL; Johnson & Johnson/Janssen; Medtronic; Olympus Medical Systems
Research Funding - AstraZeneca; Bristol-Myers Squibb; Merck; Varian Medical Systems
Travel, Accommodations, Expenses - AstraZeneca; Driver, Inc; Merck; US Oncology; Varian Medical Systems; Vindico Medical Education
 
Robert D. Timmerman
Consulting or Advisory Role - ImmuneSensor Therapeutics; Reflexion Medical
Research Funding - Accuray (Inst); Elekta (Inst); Varian Medical Systems (Inst)
 
Charles B. Simone
Honoraria - Varian Medical Systems
 
Clifford Grant Robinson
Leadership - Radialogica
Stock and Other Ownership Interests - Quantaras; Radialogica
Consulting or Advisory Role - AstraZeneca; EMD Serono; EmpNia; Quantaras; Varian Medical Systems
Research Funding - Merck (Inst); Varian Medical Systems (Inst)
Patents, Royalties, Other Intellectual Property - Noninvasive imaging and treatment system for cardiac arrhythmias WO 2017078757 A1; U.S. Provisional Application No. 62/598,162 Entitled SYSTEM AND METHOD FOR DETERMINING SEGMENTS FOR ABLATION
 
David E Gerber
Stock and Other Ownership Interests - Gilead Sciences; Walgreens
Consulting or Advisory Role - Catalyst Pharmaceuticals; Daichi Sankyo; Elevation Oncology; Janssen Oncology; Jazz Pharmaceuticals; Regeneron; Sanofi
Research Funding - AstraZeneca (Inst); BerGenBio (Inst); Karyopharm Therapeutics (Inst); Novocure (Inst)
Patents, Royalties, Other Intellectual Property - Co-founder, Chief Scientific Officer, OncoSeer Diagnostics, LLC; Royalties from Decision Support in Medicine from the Clinical Decision Support--Oncology on-line program.; Royalties from Oxford University Press from two books.; UTSD 3352 - US Patent Application 17/045,482 PREDICTION AND TREATMENT OF IMMUNOTHERAPEUTIC TOXICITY (“Chemokines” and “Cytokines”); UTSD 3352 - US Patent Application 17/045,482 PREDICTION AND TREATMENT OF IMMUNOTHERAPEUTIC TOXICITY (“Chemokines” and “Cytokines”); UTSD 4153 - US Patent Application 63/386,387 IMMUNOTHERAPY TOXICITY – CELL PHENOTYPES; UTSD 4169 - US Patent Application 63/382,972 BIOMARKERS INCLUDING RNA FOR IMMUNOTHERAPY TOXICITY; UTSD 4169 - US Patent Application 63/382,972 BIOMARKERS INCLUDING RNA FOR IMMUNOTHERAPY TOXICITY; UTSD 4184 - US Patent Application 63/382,257 T CELL TOLERANT FRACTION AS A PREDICTOR OF IMMUNE-RELATED ADVERSE EVENTS; UTSD 4184 - US Patent Application 63/382,257 T CELL TOLERANT FRACTION AS A PREDICTOR OF IMMUNE-RELATED ADVERSE EVENTS; UTSD 4287 – US Patent Application TBD INNATE AND ADAPTIVE IMMUNE FEATURES ASSOCIATED WITH TOXICITIES IN PATIENTS RECEIVING CHECKPOINT INHIBITOR THERAPY
Other Relationship - OncoSeer Diagnostics
(OPTIONAL) Uncompensated Relationships - Bristol-Myers Squibb
 
Saiama Naheed Waqar
Consulting or Advisory Role - AstraZeneca; Gilead Sciences
Research Funding - Abbvie (Inst); ARIAD (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Cullinan Pearl (Inst); Daiichi Sankyo (Inst); Elevation Oncology (Inst); Genentech (Inst); Hengrui Therapeutics (Inst); Ignyta (Inst); Janssen (Inst); Lilly (Inst); Loxo (Inst); Millennium (Inst); Newlink Genetics (Inst); Pfizer (Inst); Ribon Therapeutics (Inst); Roche (Inst); Verastem (Inst); Vertex (Inst); Xcovery (Inst)
 
Jessica Donington
Honoraria - AstraZeneca; BMS; Merck; Roche/Genentech
Consulting or Advisory Role - Amgen; AstraZeneca; BMS; Merck; Roche/Genentech
 
Stephen Swisher
Honoraria - Armada Health Care (I); AstraZeneca; AstraZeneca (I); Conquer Cancer Foundation (I); HMP (I); Interline Therapeutics (I); Merck (I); MJH Healthcare Holdings, LLC (I); Springer Science (I); Virginia Commonwealth University (I)
Consulting or Advisory Role - Armada Health Care (I); AstraZeneca; AstraZeneca (I)
Research Funding - CairnSurgical (I); Lilly (I); Lumicell (I); OncoNano Inc (I)
Travel, Accommodations, Expenses - AstraZeneca (I)
 
Michael Weldon
No Relationships to Disclose
 
Jackie Wu
No Relationships to Disclose
 
Bryan A. Faller
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Boehringer Ingelheim; Celgene; EB SQUIBB; Eisai; Genentech; Lilly; Merck; Novartis; Takeda
 
Sawsan Rashdan
Honoraria - AstraZeneca; Bristol Myers Squibb Foundation; Cardinal Health; Curio Science; G1 Therapeutics; Oncohost; Takeda; Triptych Health Partners
Consulting or Advisory Role - AstraZeneca; Bristol Myers Squibb Foundation; Cardinal Health; Catalyst Pharmaceuticals; Curio Science; G1 Therapeutics; Oncohost; Takeda
Research Funding - AstraZeneca (Inst)
 
Kevin L. Stephans
No Relationships to Disclose
 
Pamela Sampson
Honoraria - AstraZeneca; Varian Medical Systems
Travel, Accommodations, Expenses - Varian Medical Systems
 
Kristin Ann Higgins
Stock and Other Ownership Interests - Picture Health
Consulting or Advisory Role - AstraZeneca; Janssen; Reflexion Medical
Research Funding - Jazz Pharmaceuticals; Reflexion Medical
Travel, Accommodations, Expenses - AstraZeneca; AstraZeneca
 
Ryan Kenneth Nowak
No Relationships to Disclose
 
Jessica Lyness
No Relationships to Disclose
 
Jeffrey D. Bradley
Honoraria - AstraZeneca/MedImmune; Mevion Medical Systems
Consulting or Advisory Role - Genentech; Varian Medical Systems
Research Funding - Varian Medical Systems (Inst)